Novocure: HC Wainwright Keeps Buy Rating, Lowers PT to $39.

Tuesday, Jan 13, 2026 7:47 am ET1min read
NVCR--

Novocure: HC Wainwright Keeps Buy Rating, Lowers PT to $39.

Novocure: HC Wainwright Keeps Buy Rating, Lowers PT to $39.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet